Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Virtual Clinic Pacemaker Follow-up (VIRTUE)
This study is ongoing, but not recruiting participants.
Sponsored by: Biotronik GmbH & Co. KG
Information provided by: Biotronik GmbH & Co. KG
ClinicalTrials.gov Identifier: NCT00475124
  Purpose

Patients with implanted pacemakers are currently seen by their cardiologists every 6-12 months. Shorter follow-up intervals are generally seen as excessive workload for the physician, with little benefit for the patient. Longer intervals are seen as too dangerous concerning device integrity and safety. This scheme still results in a large number of follow-up visits with little or no important changes in pacemaker therapy.

Our clinical trial investigates efficacy and safety of the Home Monitoring technology for increasing the flexibility in pacemaker follow-up. Home Monitoring technology allows automatic transmission via mobile phone links of relevant data from the implanted pacemaker to a service center. The patient's physician can access the data via a password-protected internet site. The regular Home Monitoring data analyses entirely replace clinical routine visits ("virtual clinic"). Follow-up visits are scheduled according to the results of the Home Monitoring data analyses.

The primary endpoint of the study is to compare the total workload for pacemaker patient care in the virtual clinic with that of standard follow-up scheme with regularly scheduled clinical visits.


Condition Intervention Phase
Sick Sinus Syndrome
Heart Block
Bradycardia
Device: Home Monitoring of pacemaker
Device: Home Monitoring of pacemaker deactivated
Phase IV

Genetics Home Reference related topics: Brugada syndrome short QT syndrome
U.S. FDA Resources
Study Type: Interventional
Study Design: Health Services Research, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: VIRTUE: Virtual Clinic Pacemaker Follow-up

Further study details as provided by Biotronik GmbH & Co. KG:

Primary Outcome Measures:
  • Total work load for virtual clinic follow-up compared to standard follow-up (without Home Monitoring) [ Time Frame: 7 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Hospitalisation; Other serious adverse events; Quality of life; Total costs of therapy. [ Time Frame: 7 years ] [ Designated as safety issue: No ]

Enrollment: 123
Study Start Date: May 2007
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Home Monitoring ON
Device: Home Monitoring of pacemaker
Daily Home Monitoring data transmission from the implanted pacemaker to Home Monitoring service center.
2: Active Comparator
Home Monitoring OFF
Device: Home Monitoring of pacemaker deactivated
No Home Monitoring data transmission.

Detailed Description:

Patients with implanted pacemakers are currently seen by their cardiologists every 6-12 months. Shorter follow-up intervals are generally seen as excessive workload for the physician, with little benefit for the patient. Longer intervals are seen as too dangerous concerning device integrity and safety. This scheme still results in a large number of follow-up visits with little or no important changes in pacemaker therapy. On the other hand, in some patients there are quicker changes in their cardiac situation and the need for subsequent adaptation of pacemaker programming, which cannot be detected and properly treated with standard follow-up scheme.

Our clinical trial investigates efficacy and safety of the Home Monitoring technology for increasing the flexibility in pacemaker follow-up. Home Monitoring technology allows automatic transmission via mobile phone links of relevant data from the implanted pacemaker to a service center. The patient's physician can access the data via a password-protected internet site. The regular Home Monitoring data analyses entirely replace clinical routine visits ("virtual clinic"). Follow-up visits are scheduled according to the results of the Home Monitoring data analyses.

For the primary endpoint, the total workload for pacemaker patient care in the virtual clinic is compared to that of a standard follow-up scheme with regular clinic visits. The total workload comprises the time for data analyses, clinical examinations, and other patient contacts.

Secondary endpoints investigate adverse events rate, quality of life, and total costs, as mirrored by direct patient's expenses, and patient travel and waiting time, for visits to the pacer clinic as well as to additional cardiologist's or internal medicine doctor's services.

Standard vs. virtual follow-up. For the standard follow-up group patients, routine follow-up visits are scheduled 1 month and 12 months after pre-discharge control, and then every 12 months. A follow-up at 6 months after discharge is optional. For the virtual clinic group patients, a routine follow-up visit is scheduled 1 month after pre-discharge control. The Home Monitoring data analyses have to be performed 12 months after discharge, and then every 12 months. If a 6-month follow-up is routinely done for the standard group in the clinic, a 6-month Home Monitoring data analysis has to be done as well. Event reports have to be analysed within 24 hours during working days.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Indication for implantation of dual-chamber rate-adaptive pacemaker
  • Stable medical situation
  • Patient informed consent

Exclusion Criteria:

  • Contra-indication for implantation of dual-chamber rate-adaptive pacemaker
  • Persistent atrial fibrillation
  • Replacement indication
  • Participation in another clinical trial
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00475124

Locations
United Kingdom
St. Peter's Hospital
Chertsey, United Kingdom, KT16 0QA
Basildon Hospital
Basildon, United Kingdom, SS16 5NL
Newcross Hospital
Wolverhampton, United Kingdom, WV10 0QP
Barnet & Chase Farm Hospital
Barnet, United Kingdom, EN5 3DJ
North Middlesex University Hospital
London, United Kingdom, N18 1QX
Russels Hall Hospital
Dudley, United Kingdom, DY1 2HQ
Sponsors and Collaborators
Biotronik GmbH & Co. KG
Investigators
Study Chair: David Fluck, Dr. St. Peter's Hospital, Chertsey, UK
  More Information

Responsible Party: Biotronik GmbH & Co. KG ( Petra Maier )
Study ID Numbers: HS036
Study First Received: May 16, 2007
Last Updated: January 12, 2009
ClinicalTrials.gov Identifier: NCT00475124  
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Keywords provided by Biotronik GmbH & Co. KG:
Pacemaker follow-up
Telecardiology
Home Monitoring

Study placed in the following topic categories:
Heart Diseases
Arrhythmia, Sinus
Heart Block
Bradycardia
Sick Sinus Syndrome
Arrhythmias, Cardiac

Additional relevant MeSH terms:
Disease
Pathologic Processes
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009